55 results
Page 3 of 3
6-K
EX-99.1
k9k44 r2cpe
11 Sep 20
Current report (foreign)
8:16am
6-K
EX-99.1
q223e90lr
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
6-K
EX-99.1
rua26xw9vs5cxgi
13 Aug 20
Current report (foreign)
7:30am
6-K
EX-99.1
r1p8sv7y44v8m49r6c5
19 Mar 20
Current report (foreign)
7:53am
424B2
dlm1 le38wjjc
24 Jan 20
Prospectus for primary offering
7:24am
424B5
nvv4nca xwqd
21 Jan 20
Prospectus supplement for primary offering
5:31pm
6-K
EX-99.1
im4 s0zqdo9tub
27 Dec 19
Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) in China as Maintenance Therapy for Patients with Recurrent Ovarian Cancer
7:51am
6-K
EX-99.1
q4h3t8l5hhgwy
3 Sep 19
Current report (foreign)
7:40am
6-K
EX-99.1
xdccwqd
7 Mar 19
Zai Lab Announces Financial Results and Corporate Update for Full Year 2018
7:36am
424B4
wgujm h719m1np
7 Sep 18
Prospectus supplement with pricing info
12:00am
20-F
i367 fnje4fywbcjo
30 Apr 18
Annual report (foreign)
9:07am